HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes rats.

Abstract
In this study, we examined alterations in the enzymatic antioxidant defenses associated with learning deficits induced by type 2 diabetes, and studied the effects of the peroxisome proliferator-activated receptor γ agonist pioglitazone on these learning deficits. Learning ability was assessed by visual discrimination tasks in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, as a model of spontaneous type 2 diabetes. Levels of the antioxidant enzymes glutathione peroxidase (GPx), Cu(2+)-Zn(2+) superoxide dismutase (CuZn-SOD) and manganese SOD were measured in the cortex, hippocampus and striatum. Half the rats received oral pioglitazone (20mg/kg/day) from the early stage of diabetes (22 weeks old) to 27 weeks old. OLETF rats showed learning deficits compared with control, Long-Evans Tokushima Otsuka (LETO) rats. GPx levels in the cortex and hippocampus were increased in OLETF rats compared with LETO rats, with an inverse correlation between GPx in the hippocampus and learning score. CuZn-SOD levels were also increased in the hippocampus in OLETF rats. Pioglitazone reduced blood glucose and increased serum adiponectin levels, but had no effect on learning tasks or antioxidant enzymes, except for CuZn-SOD. These results suggest that an oxidative imbalance reflected by increased brain antioxidant enzymes plays an important role in the development of learning deficits in type 2 diabetes. Early pioglitazone administration partly ameliorated diabetic symptoms, but was unable to completely recover cerebral oxidative imbalance and functions. These results suggest that diabetes-induced brain impairment, which results in learning deficits, may have occurred before the appearance of the symptoms of overt diabetes.
AuthorsRie Suge, Tomokazu Shimazu, Hajime Hasegawa, Ikuo Inoue, Hidemasa Hayashibe, Hironori Nagasaka, Nobuo Araki, Shigehiro Katayama, Masahiko Nomura, Shu-Ichi Watanabe
JournalBrain research (Brain Res) Vol. 1481 Pg. 97-106 (Oct 24 2012) ISSN: 1872-6240 [Electronic] Netherlands
PMID22981416 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Adiponectin
  • Antioxidants
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Glutathione Peroxidase
  • Sod1 protein, rat
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • superoxide dismutase 2
  • Pioglitazone
  • Glutathione Peroxidase GPX1
  • Gpx1 protein, rat
Topics
  • Adiponectin (blood)
  • Animals
  • Antioxidants (metabolism)
  • Brain (enzymology)
  • Cerebral Cortex (enzymology)
  • Conditioning, Operant (drug effects, physiology)
  • Corpus Striatum (enzymology)
  • Diabetes Mellitus, Type 2 (drug therapy, metabolism, physiopathology)
  • Disease Models, Animal
  • Glutathione Peroxidase (metabolism)
  • Hippocampus (enzymology)
  • Hypoglycemic Agents (pharmacology)
  • Learning Disabilities (metabolism, physiopathology)
  • Male
  • Memory Disorders (metabolism, physiopathology)
  • Pioglitazone
  • Rats
  • Rats, Inbred OLETF
  • Species Specificity
  • Superoxide Dismutase (metabolism)
  • Superoxide Dismutase-1
  • Thiazolidinediones (pharmacology)
  • Glutathione Peroxidase GPX1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: